Clinical practice and recent recommendations in hypertension management - Reporting a gap in a global survey of 1259 primary care physicians in 17 countries

Current Medical Research and Opinion

Volumn 23, Issue 4, 2007, Pages 783-791

  Bramlage, Peter ^a   Thoenes, Martin ^a,b   Kirch, Wilhelm ^a   Lenfant, Claude ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b SANOFI   (France)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Awareness; Blood pressure; Goal; Hypertension; Treatment strategies

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; HYPERTENSION; INTERVENTION STUDY; INTERVIEW; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; TREATMENT FAILURE;

ATTITUDE OF HEALTH PERSONNEL; AWARENESS; BLOOD PRESSURE; DRUG THERAPY; GEOGRAPHY; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; INTERVIEWS; PERCEPTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, FAMILY; QUESTIONNAIRES; RANDOM ALLOCATION;

EID: 34247399899     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X182077     Document Type: Article

References (51)

1. Lawes CM, Vander Hoorn S, Law MR, et al. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006;24:423-30
2. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23
3. Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-60
4. Franco OH, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 2005;46:280-6
5. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74
6. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38
7. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13
8. Wiklund I, Halling K, Ryden-Bergsten T, Fletcher A. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. Blood Press 1997;6:357-64
9. ESH/ESC. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53
10. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. J Am Med Assoc 2003;289:2560-71
11. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. J Am Med Assoc 2003;290:199-206
12. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-7
13. Petrella RJ, Merikle EP, Jones J. Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities. J Clin Hypertens (Greenwich) 2007;9:28-35
14. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4
15. Leenen FH, Wilson TW, Bolli P, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol 1997;13:914-20
16. Fincke BG, Miller DR, Spiro 3rd A. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med 1998;13:182-5
17. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healdicare professionals. Circulation 1997;95:1085-90
18. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. New Engl J Med 1998;339:1957-63
19. Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002;162:413-20
20. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 2000;160:2281-6
21. Sharma AM, Wittchen HU, Kirch W, et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004;22:479-86
22. Schappert SM, Nelson C. National ambulatory medical care survey: 1995-96 summary. Washington: DHHS Government Printing Office
23. Alexander M, Gordon NP, Davis CC, Chen RS. Patient knowledge and awareness of hypertension is suboptimal: results from a large health maintenance organization. J Clin Hypertens (Greenwich) 2003;5:254-60
24. Cheng S, Lichtman JH, Amatruda JM, et al. Knowledge of blood pressure levels and targets in patients with coronary artery disease in the USA. J Hum Hypertens 2005;19:769-74
25. Oliveria SA, Chen RS, McCarthy BD, et al. Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med 2005;20:219-25
26. Margolis KL, Rolnick SJ, Fortman KK, et al. Self-reported hypertension treatment beliefs and practices of primary care physicians in a managed care organization. Am J Hypertens 2005;18:566-71
27. Dusing R. [Adherence to medical treatment.]. Dtsch Med Wochenschr 2006;131:H28-30
28. van Wyk JT, Picelli G, Dieleman JP, et al. Management of hypertension and hypercholesterolaemia in primary care in The Netherlands. Curr Med Res Opin 2005;21:839-48
29. van Wyk JT, van Wijk MA, Sturkenboom MC, et al. Identification of the four conventional cardiovascular disease risk factors by Dutch general practitioners. Chest 2005;128:2521-7
30. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Br Med J 2003;326:1427-31
31. Garg JP, Elliott WJ, Folker A, et al. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 2005;18:619-26
32. Moser M, Black HR. The role of combination therapy in the treatment of hypertension. Am J Hypertens 1998;11:73S-8S [discussion 95S-100S]
33. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-404
34. Hansson L, Zanchetti A, Carruthers S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial [HOT Study Group]. Lancet 1998;351:1755-62
35. Elliott WJ. Is fixed combination therapy appropriate for initial hypertension treatment? Curr Hypertens Rep 2002;4:278-85
36. Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006;47:345-51
37. Stolk P, Van Wijk BL, Leufkens HG, Heerdink ER. Between-country variation in the utilization of antihypertensive agents: guidelines and clinical practice. J Hum Hypertens 2006;20:917-22
38. Sowers JR, Neutel JM, Saunders E, et al. Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes. J Clin Hypertens (Greenwich) 2006;8:470-80
39. de Tuero GC, Boreu QF, Rodriguez-Poncelas A, et al. Assessment of self-monitoring of blood pressure in the diagnosis of isolated clinic hypertension. Blood Press 2006;15:227-36
40. Franklin SS. Hypertension in older people: part 2. J Clin Hypertens (Greenwich) 2006;8:521-5
41. Pannarale G, Licitra R, Leonetti S, et al. Evaluation of systolic blood pressure control in elderly patients with isolated systolic hypertension. Eur Rev Med Pharmacol Sci 2006;10:111-4
42. Bramlage P, Bramlage C, Kirch W. [Antihypertensive drug utilization in obese patients]. Med Klin (Munich) 2005;100:804-9
43. Bramlage P, Pittrow D, Wittchen H, et al. High body mass index is associated with an increased prevalence and lack of control of hypertension. Am J Hypertens 2004;17:904-10
44. Volpe M, Dedhiya SD. Physicians, patients, and public knowledge and perception regarding hypertension and stroke: a review of survey studies. Curr Med Res Opin 2006;22:1319-30
45. Menard J, Chatellier G. Limiting factors in the control of BP: why is there a gap between theory and practice? J Hum Hypertens 1995;9(Suppl 2):S19-S23
46. WHO. Adherence to long-term therapies: evidence for action. 2003
47. Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004;22:1849-55
48. Brodsky MA, Chun JG, Podrid PJ, et al. Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation. Arch Intern Med 1996;156:2553-62
49. Hoffman RM, Papenfuss MR, Buller DB, Moon TE. Attitudes and practices of primary care physicians for prostate cancer screening. Am J Prevent Med 1996;12:277-81
50. Friedmann PD, Brett AS, Mayo-Smidi MF. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med 1996;124:414-21
51. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50:1129-36